Expression of galectins in head and neck squamous cell carcinoma

被引:0
|
作者
Gillenwater, A
Xu, XC
ElNaggar, AK
Clayman, GL
Lotan, R
机构
[1] UNIV TEXAS, MD ANDERSON CANCER CTR, DEPT TUMOR BIOL, HOUSTON, TX 77030 USA
[2] UNIV TEXAS, MD ANDERSON CANCER CTR, DEPT PATHOL, HOUSTON, TX 77030 USA
关键词
D O I
10.1002/(SICI)1097-0347(199609/10)18:5<422::AID-HED5>3.0.CO;2-7
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. Galectins are carbohydrate-binding proteins thought to be important for cell growth and differentiation, whose expression is altered in some tumors with aggressive phenotype. Our objective was to evaluate the expression of galectins in head and neck squamous cell carcinoma (HNSCC). Methods. Fourteen HNSCC cell lines and four primary tumor specimens were evaluated using immunoblotting, and immunohistochemical analysis was performed on 35 primary HNSCCs. Results. Galectin-1 and galectin-3 were expressed in most HNSCC cell lines and primary tumor specimens. Galectin-1 was detected in the basal layer of normal adjacent mucosa, in connective tissue stroma, and at the periphery of invasive tumor islands. Galectin-3 localized to superficial mucosal layers, and adjacent to keratin pearls in invasive carcinoma. Conclusions. Galectins are manifested in HNSCC tumors and are localized to the cell surface, where they may participate in cellular interactions. The expression pattern of galectins appears to be associated with degree of squamous differentiation, suggesting a potential role for galectins as biologic and differentiation markers in HNSCC. (C) 1996 John Wiley & Sons, Inc.
引用
收藏
页码:422 / 432
页数:11
相关论文
共 50 条
  • [31] Expression of cdk6 in head and neck squamous cell carcinoma
    Sopee Poomsawat
    Sirima Sanguansin
    Jirapa Punyasingh
    Paisarn Vejchapipat
    Phaibul Punyarit
    Clinical Oral Investigations, 2016, 20 : 57 - 63
  • [32] EGFR expression in advanced head and neck cutaneous squamous cell carcinoma
    Sweeny, Larissa
    Dean, Nichole R.
    Magnuson, J. Scott
    Carroll, William R.
    Helman, Emily E.
    Hyde, Stephen O.
    Desmond, Renee L.
    Rosenthal, Eben L.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2012, 34 (05): : 681 - 686
  • [33] Immune gene expression in head and neck squamous cell carcinoma patients
    Lecerf, Charlotte
    Kamal, Maud
    Vacher, Sophie
    Chemlali, Walid
    Schnitzler, Anne
    Morel, Claire
    Dubot, Coraline
    Jeannot, Emmanuelle
    Meseure, Didier
    Klijanienko, Jerzy
    Mariani, Odette
    Borcoman, Edith
    Calugaru, Valentin
    Badois, Nathalie
    Chilles, Anne
    Lesnik, Maria
    Krhili, Samar
    Choussy, Olivier
    Hoffmann, Caroline
    Piaggio, Eliane
    Bieche, Ivan
    Le Tourneau, Christophe
    EUROPEAN JOURNAL OF CANCER, 2019, 121 : 210 - 223
  • [34] Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma
    Nakashima, T
    Yasumatsu, R
    Kuratomi, Y
    Masuda, M
    Kuwano, T
    Toh, S
    Umezaki, T
    Cataltepe, S
    Silverman, GA
    Komune, S
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2006, 28 (01): : 24 - 30
  • [35] Revisiting Multi-Omics Data to Unravel Galectins as Prognostic Factors in Head and Neck Squamous Cell Carcinoma
    Barros, Oriana
    D'Agostino, Vito Giuseppe
    Santos, Lucio
    Ferreira, Rita
    Vitorino, Rui
    BIOMEDICINES, 2024, 12 (03)
  • [36] Biomarkers of squamous cell carcinoma of the head and neck
    Kim, J
    Shin, DM
    HISTOLOGY AND HISTOPATHOLOGY, 1997, 12 (01) : 205 - 218
  • [37] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Moskovitz, Jessica
    Moy, Jennifer
    Ferris, Robert L.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (02)
  • [39] Afatinib in squamous cell carcinoma of the head and neck
    Specenier, Pol
    Vermorken, Jan
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (09) : 1295 - 1301
  • [40] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Hoesli R.C.
    Moyer J.S.
    Current Oral Health Reports, 2016, 3 (2) : 74 - 81